{"schema_version":"secwatch.filing_event.v1","accession":"0000886163-25-000042","form_type":"8-K","ticker":"LGND","cik":"0000886163","company_name":"LIGAND PHARMACEUTICALS INC","filed_at":"2025-07-02T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.590496+00:00","generated_at":"2026-05-18T09:51:20.315012+00:00","sec_items":["7.01","9.01"],"event_type":"m_and_a","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ligand completes merger with Channel Therapeutics; Pelthos starts trading July 2 under PTHS","bullets":["Ligand subsidiary merges with Channel; combined company renamed Pelthos Therapeutics, trading on NYSE American as PTHS.","Ligand invests $18M in Pelthos; entitled to 13% royalty on worldwide net sales of ZELSUVMI.","Pelthos raises total $50.1M equity from Ligand and Murchinson-led investor group.","ZELSUVMI (berdazimer) topical gel, FDA-approved for molluscum, to launch July 2025; first at-home prescription treatment.","Pelthos to also evaluate Channel's NaV 1.7 pain development programs for chronic pain and eye pain."],"urls":{"canonical":"https://secwatch.observer/filing/0000886163-25-000042","json":"https://secwatch.observer/filing/0000886163-25-000042.json","markdown":"https://secwatch.observer/filing/0000886163-25-000042.md","text":"https://secwatch.observer/filing/0000886163-25-000042.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/886163/000088616325000042/0000886163-25-000042-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/886163/000088616325000042/lgnd-20250702.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T09:51:20.315012+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}